Fulminant Hepatic Failure in Children
Authors:
- Douglas G. FarmerDFDouglas G. Farmer
- Robert S. VenickRVRobert S. Venick
- Sue V. McDiarmidSMSue V. McDiarmid
- John P. DuffyJDJohn P. Duffy
- Omar KattanOKOmar Kattan
- Johnny C. HongJHJohnny C. Hong
- Jorge VargasJVJorge Vargas
- Hasan YersizHYHasan Yersiz
- Ronald W. BusuttilRBRonald W. Busuttil
- 1 September 2009
- journal article
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 250 (3) , 484-493
Abstract
Death occurs in half of all children with fulminant hepatic failure (FHF). Although liver transplantation (LT) is potentially life-saving, there are only a few published series with limited experience. The aim was to examine predictors of survival after LT for FHF. Between 1984 and 2008, all LT for FHF performed in recipients less than or equal to 18 years of age were analyzed from a prospectively maintained database using 35 demographic, laboratory, and operative variables. Unique calculated variables included creatinine clearance (cCrCl) and Pediatric End-Stage Liver Disease score (PELD). Study end-points were patient and death censored graft survival. Median follow-up was 98 months. Statistical analysis involved the log-rank test and Cox proportional hazards model. A total of 122 children underwent 159 LTx. Cryptogenic was the primary etiology (70%) and the median age was 53 months. The significant (P < 0.05) univariate predictors of worse graft survival were: recipient age 60 minutes. The significant (P < 0.05) univariate predictors of worse patient survival were: recipient African-American and Asian race, recipient age <24 months, cCrCl <60 mL/min/1.73m2, and time from onset jaundice to encephalopathy <7 days. On multivariate analysis, survival was significantly impacted by 4 variables: cCrCl 25 points (GRAFT), recipient age <24 months (GRAFT), and time from onset jaundice to encephalopathy <7 days (PATIENT). While overall 5- and 10-year survival was 73% and 72% (GRAFT) and 77% and 73% (PATIENT), these were significantly worse when a combination of multivariate risk-factors were present. This data from a large, single-center experience demonstrates that LT is the treatment of choice for FHF and results in durable survival. Analysis revealed 4 novel outcome predictors. Young children with rapid onset acute liver failure are a high-risk subpopulation. Unique to this study, cCrCl and PELD accurately predicted the end-points. This analysis identifies patient subpopulations requiring early aggressive intervention with LT.Keywords
This publication has 33 references indexed in Scilit:
- Acute liver failureHepatology, 2007
- Predictors of Outcomes after Pediatric Liver Transplantation: An Analysis of More Than 800 Cases Performed at a Single InstitutionJournal of the American College of Surgeons, 2007
- Acute liver failure in children: The first 348 patients in the pediatric acute liver failure study groupThe Journal of Pediatrics, 2006
- The pediatric end-stage liver disease (PELD) model as a predictor of survival benefit and posttransplant survival in pediatric liver transplant recipientsLiver Transplantation, 2006
- Bone marrow dysfunction following pediatric liver transplantationPediatric Transplantation, 2005
- Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function1Transplantation, 2004
- Mortality risk factors of a pediatric population with fulminant hepatic failure undergoing orthotopic liver transplantation in a pediatric intensive care unit*Pediatric Critical Care Medicine, 2002
- Orthotopic Liver Transplantation in Fulminant and Subfulminant Hepatitis The Paul Brousse ExperienceAnnals of Surgery, 1995
- A simple estimate of glomerular filtration rate in adolescent boysThe Journal of Pediatrics, 1985
- A simple estimate of glomerular filtration ratein full-term infants during the first year of lifeThe Journal of Pediatrics, 1984